A 75-year-old Caucasian male developed redness on the surface of the right eye (OD) [ Fig. 1a ] that persisted for 6 months. Surgical excision revealed amelanotic conjunctival melanoma without primary acquired melanosis [ Fig. 1b ]. Eight years later, he noted mild recurrent redness on the opposite side of the OD, appearing as an inflamed pingueculum [ Fig. 1c ].
Diagnosis
Conjunctival amelanotic melanoma.
Correct Answer: D.
Discussion
Conjunctival malignant melanoma (CMM) represents 0.25% of melanomas. [1] Typical management includes complete surgical resection and cryotherapy. [2] Adjuvant therapy is considered to prevent tumor recurrence and metastasis. [2] Wong et al. reported up to 45% local recurrence and 42% systemic metastasis in 5 years. [1] Similar to cutaneous melanoma, CMM has been associated with BRAF, c-KIT, and NRAS mutations. [2] NRAS mutations have been associated with more aggressive disease and decreased survival. [3] While no approved NRAS-specific targeted therapies are currently available, immune-based therapies such as interleukin-2 (IL-2), anti-CTLA4 antibody (ipilimumab), and anti-PD1 treatment (nivolumab and pembrolizumab) are now first-line treatments for NRAS-mutated cutaneous melanoma. [3] 
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